What is it about?
Dr. Alan Michelson and I provide our perspective on how we use (or don't use) laboratory monitoring of antiplatelet therapy.
Featured Image
Why is it important?
In some clinical settings, laboratory monitoring of antiplatelet therapy is common, but there is a scarcity of randomized clinical trial data supporting the practice.
Perspectives
We need much more randomized clinical trial data before widespread adoption of laboratory monitoring of antiplatelet therapy.
Professor Deepak L Bhatt
Brigham and Women's Hospital and Harvard Medical School
Read the Original
This page is a summary of: How I utilize laboratory monitoring of antiplatelet therapies, Blood, June 2017, American Society of Hematology,
DOI: 10.1182/blood-2017-03-742338.
You can read the full text:
Contributors
The following have contributed to this page
